Nano-X Imaging Ltd. (NASDAQ:NNOX) Shares Sold by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. reduced its stake in Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) by 79.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,294 shares of the company's stock after selling 74,401 shares during the period. Balyasny Asset Management L.P.'s holdings in Nano-X Imaging were worth $139,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of NNOX. JPMorgan Chase & Co. increased its holdings in Nano-X Imaging by 16.7% in the third quarter. JPMorgan Chase & Co. now owns 41,364 shares of the company's stock valued at $251,000 after buying an additional 5,930 shares during the last quarter. SG Americas Securities LLC increased its holdings in Nano-X Imaging by 20.6% in the fourth quarter. SG Americas Securities LLC now owns 24,661 shares of the company's stock valued at $178,000 after buying an additional 4,218 shares during the last quarter. Wesbanco Bank Inc. purchased a new position in Nano-X Imaging in the fourth quarter valued at $178,000. Kingsview Wealth Management LLC purchased a new position in Nano-X Imaging in the fourth quarter valued at $94,000. Finally, Rhumbline Advisers grew its holdings in shares of Nano-X Imaging by 2.4% during the fourth quarter. Rhumbline Advisers now owns 71,972 shares of the company's stock worth $518,000 after purchasing an additional 1,655 shares during the last quarter. 21.49% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Cantor Fitzgerald dropped their price objective on Nano-X Imaging from $12.00 to $9.00 and set an "overweight" rating on the stock in a report on Tuesday, April 1st. Alliance Global Partners reaffirmed a "buy" rating on shares of Nano-X Imaging in a report on Thursday. Finally, D. Boral Capital dropped their price objective on Nano-X Imaging from $15.00 to $10.00 and set a "buy" rating on the stock in a report on Friday.

Nano-X Imaging Trading Down 2.1%

Shares of NNOX traded down $0.11 during mid-day trading on Friday, hitting $5.13. 745,119 shares of the company's stock were exchanged, compared to its average volume of 1,740,170. Nano-X Imaging Ltd. has a fifty-two week low of $3.75 and a fifty-two week high of $11.00. The firm has a market capitalization of $296.41 million, a P/E ratio of -6.04 and a beta of 2.03. The business's 50 day moving average is $5.11 and its two-hundred day moving average is $6.34.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported ($0.21) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.02. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. The business had revenue of $3.00 million during the quarter, compared to the consensus estimate of $3.98 million. On average, equities research analysts forecast that Nano-X Imaging Ltd. will post -0.92 earnings per share for the current year.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.